Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Galera Therapeutics Inc increased its cash reserves by 323.01%, or 13.94m. Cash Flow from Financing totalled 31.50m or -- of revenues. In addition the company used 44.85m for operations while cash from investing totalled 27.29m.
Cash flow per share | -0.553 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -2.54 |
---|---|
Tangible book value per share | -2.60 |
More ▼
Balance sheet in USDView more
Current ratio | 5.63 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 11.60 |
More ▼